EMA-话题@MedSci

#EMA#

580篇内容 | 2463人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317433, encodeId=1e3f131e433f3, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Dent Mater J：不同搅动方式对HEMA-free通用型牙本质粘接剂粘接层形成的影响, objectType=article, longId=153014, objectId=0fb3153014e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fb3153014e5, replyNumber=0, likeNumber=63, createdTime=2018-11-09, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fb3153014e5, moduleTitle=Dent Mater J：不同搅动方式对HEMA-free通用型牙本质粘接剂粘接层形成的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fb3153014e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317432, encodeId=accd131e432d3, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：老年AML新的低强度方案：克拉屈滨+低剂量阿糖胞苷交替地西他宾, objectType=article, longId=152647, objectId=6ddf15264e3b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ddf15264e3b, replyNumber=0, likeNumber=93, createdTime=2018-11-04, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ddf15264e3b, moduleTitle=Lancet Haematol：老年AML新的低强度方案：克拉屈滨+低剂量阿糖胞苷交替地西他宾, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ddf15264e3b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317431, encodeId=0079131e431ad, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA委员会建议批准赛诺菲的登革病毒疫苗Dengvaxia, objectType=article, longId=151517, objectId=8aab15151e6c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8aab15151e6c, replyNumber=0, likeNumber=76, createdTime=2018-10-23, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8aab15151e6c, moduleTitle=EMA委员会建议批准赛诺菲的登革病毒疫苗Dengvaxia, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8aab15151e6c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317430, encodeId=8bca131e43050, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Cell Physiol：通过定量蛋白质组学分析揭示SEMA3B-AS1抑制人间充质干细胞的成骨分化, objectType=article, longId=151299, objectId=6b1015129915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b1015129915, replyNumber=0, likeNumber=73, createdTime=2018-10-19, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b1015129915, moduleTitle=J Cell Physiol：通过定量蛋白质组学分析揭示SEMA3B-AS1抑制人间充质干细胞的成骨分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b1015129915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317429, encodeId=5f8d131e4297a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：深静脉血栓形成后，标准弹性加压治疗持续时间其实没必要那么长, objectType=article, longId=150716, objectId=110a150e16d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=110a150e16d0, replyNumber=0, likeNumber=63, createdTime=2018-10-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=110a150e16d0, moduleTitle=Lancet haemat：深静脉血栓形成后，标准弹性加压治疗持续时间其实没必要那么长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=110a150e16d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317428, encodeId=5242131e42804, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子, objectType=article, longId=148690, objectId=adeb1486905b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adeb1486905b, replyNumber=0, likeNumber=17, createdTime=2018-09-13, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adeb1486905b, moduleTitle=Haematologica：TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adeb1486905b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317427, encodeId=5bef131e42751, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=CLIN CANCER RES：Abemaciclib增强非小细胞肺癌放疗敏感性, objectType=article, longId=147813, objectId=6aba14e813e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aba14e813e7, replyNumber=0, likeNumber=70, createdTime=2018-09-01, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aba14e813e7, moduleTitle=CLIN CANCER RES：Abemaciclib增强非小细胞肺癌放疗敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aba14e813e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317426, encodeId=73f7131e42621, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=双膦酸盐与狄诺塞麦治疗PMOP的“药物假期”EMAS立场声明要点解读, objectType=article, longId=147376, objectId=9a3e14e3768c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a3e14e3768c, replyNumber=0, likeNumber=14, createdTime=2018-08-26, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a3e14e3768c, moduleTitle=双膦酸盐与狄诺塞麦治疗PMOP的“药物假期”EMAS立场声明要点解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a3e14e3768c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317425, encodeId=ea55131e4254b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Neurology：Fremanezumab对恢复偏头痛患者日常功能效果显著, objectType=article, longId=147069, objectId=fea514e06970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fea514e06970, replyNumber=0, likeNumber=70, createdTime=2018-08-22, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fea514e06970, moduleTitle=Neurology：Fremanezumab对恢复偏头痛患者日常功能效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fea514e06970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317424, encodeId=220d131e4241f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Br J Haematol：开始治疗时间也是侵袭性非霍奇金淋巴瘤的独立预后因素？, objectType=article, longId=146869, objectId=030e146869df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=030e146869df, replyNumber=0, likeNumber=80, createdTime=2018-08-19, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=030e146869df, moduleTitle=Br J Haematol：开始治疗时间也是侵袭性非霍奇金淋巴瘤的独立预后因素？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=030e146869df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317423, encodeId=d159131e42367, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Br J Haematol：阿扎胞苷，7号染色体异常的高风险MDS患者的福音？, objectType=article, longId=146868, objectId=51c81468682a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51c81468682a, replyNumber=0, likeNumber=61, createdTime=2018-08-19, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51c81468682a, moduleTitle=Br J Haematol：阿扎胞苷，7号染色体异常的高风险MDS患者的福音？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51c81468682a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317422, encodeId=c6de131e42272, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：CLL一线抢救治疗，BR pk 依鲁替尼, objectType=article, longId=146866, objectId=0ef814686687, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ef814686687, replyNumber=0, likeNumber=93, createdTime=2018-08-19, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ef814686687, moduleTitle=Haematologica：CLL一线抢救治疗，BR pk 依鲁替尼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ef814686687)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317421, encodeId=e0f2131e42173, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Pediatr Hematol Oncol：实体肿瘤儿童中，顺铂诱导的耳毒性研究, objectType=article, longId=146707, objectId=8cb3146e0761, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cb3146e0761, replyNumber=0, likeNumber=61, createdTime=2018-08-17, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cb3146e0761, moduleTitle=J Pediatr Hematol Oncol：实体肿瘤儿童中，顺铂诱导的耳毒性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cb3146e0761)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317420, encodeId=af6b131e4203d, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA授予AZ和MSD公司MEK抑制剂孤儿药资格用于治疗1型神经纤维瘤, objectType=article, longId=145835, objectId=24c4145835bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24c4145835bc, replyNumber=0, likeNumber=57, createdTime=2018-08-05, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24c4145835bc, moduleTitle=EMA授予AZ和MSD公司MEK抑制剂孤儿药资格用于治疗1型神经纤维瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24c4145835bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317419, encodeId=e2ae131e4190b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA限制使用前列腺癌药物Xofigo, objectType=article, longId=145481, objectId=c24c145481c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c24c145481c4, replyNumber=0, likeNumber=61, createdTime=2018-07-31, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c24c145481c4, moduleTitle=EMA限制使用前列腺癌药物Xofigo, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c24c145481c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317418, encodeId=bc8a131e418bb, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol:「CAR-T疗效不佳」，可能是肿瘤微环境引发的T细胞衰老, objectType=article, longId=145441, objectId=e0d214544180, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0d214544180, replyNumber=0, likeNumber=56, createdTime=2018-07-31, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0d214544180, moduleTitle=J Hematol Oncol:「CAR-T疗效不佳」，可能是肿瘤微环境引发的T细胞衰老, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0d214544180)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317417, encodeId=b4cb131e41767, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA支持批准Amgen的Neulasta的第一个生物仿制药版本, objectType=article, longId=145379, objectId=2d8b1453e9a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d8b1453e9a0, replyNumber=0, likeNumber=55, createdTime=2018-07-30, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d8b1453e9a0, moduleTitle=EMA支持批准Amgen的Neulasta的第一个生物仿制药版本, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d8b1453e9a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317416, encodeId=c3e7131e4161a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：腹壁成形减肥术后贫血补铁静脉优于口服吗？, objectType=article, longId=145263, objectId=43b114526386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43b114526386, replyNumber=0, likeNumber=58, createdTime=2018-07-28, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43b114526386, moduleTitle=Lancet Haematol：腹壁成形减肥术后贫血补铁静脉优于口服吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43b114526386)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317415, encodeId=8378131e41500, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Brit J Haematol：R/R-AML患者 HSCT前用高剂量美法仑更有利？, objectType=article, longId=144794, objectId=13f5144e942c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13f5144e942c, replyNumber=0, likeNumber=56, createdTime=2018-07-21, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13f5144e942c, moduleTitle=Brit J Haematol：R/R-AML患者 HSCT前用高剂量美法仑更有利？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13f5144e942c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317414, encodeId=8a79131e4146a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：来那度胺+MEC治疗复发/难治AML患者的耐受性如何？, objectType=article, longId=144790, objectId=024b144e90ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=024b144e90ed, replyNumber=0, likeNumber=58, createdTime=2018-07-21, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=024b144e90ed, moduleTitle=Am J Hematol：来那度胺+MEC治疗复发/难治AML患者的耐受性如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=024b144e90ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EMA

2020-05-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Dent Mater J：不同搅动方式对HEMA-free通用型牙本质粘接剂粘接层形成的影响

2018-11-09

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：老年AML新的低强度方案：克拉屈滨+低剂量阿糖胞苷交替地西他宾

2018-11-04

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA委员会建议批准赛诺菲的登革病毒疫苗Dengvaxia

2018-10-23

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Cell Physiol：通过定量蛋白质组学分析揭示SEMA3B-AS1抑制人间充质干细胞的成骨分化

2018-10-19

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：深静脉血栓形成后，标准弹性加压治疗持续时间其实没必要那么长

2018-10-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子

2018-09-13

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

CLIN CANCER RES：Abemaciclib增强非小细胞肺癌放疗敏感性

2018-09-01

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

双膦酸盐与狄诺塞麦治疗PMOP的“药物假期”EMAS立场声明要点解读

2018-08-26

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Neurology：Fremanezumab对恢复偏头痛患者日常功能效果显著

2018-08-22

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Br J Haematol：开始治疗时间也是侵袭性非霍奇金淋巴瘤的独立预后因素？

2018-08-19

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Br J Haematol：阿扎胞苷，7号染色体异常的高风险MDS患者的福音？

2018-08-19

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：CLL一线抢救治疗，BR pk 依鲁替尼

2018-08-19

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Pediatr Hematol Oncol：实体肿瘤儿童中，顺铂诱导的耳毒性研究

2018-08-17

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA授予AZ和MSD公司MEK抑制剂孤儿药资格用于治疗1型神经纤维瘤

2018-08-05

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA限制使用前列腺癌药物Xofigo

2018-07-31

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol:「CAR-T疗效不佳」，可能是肿瘤微环境引发的T细胞衰老

2018-07-31

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA支持批准Amgen的Neulasta的第一个生物仿制药版本

2018-07-30

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：腹壁成形减肥术后贫血补铁静脉优于口服吗？

2018-07-28

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Brit J Haematol：R/R-AML患者 HSCT前用高剂量美法仑更有利？

2018-07-21

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：来那度胺+MEC治疗复发/难治AML患者的耐受性如何？

2018-07-21

科室
- - 订阅+
  - 更多科室
工具
服务